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Abstract
 
Localized cutaneous herpes simplex virus type 1 (HSV-1) infection leads to arming and initial
expansion of cytotoxic T lymphocytes (CTLs) in the draining popliteal lymph nodes (PLNs)
followed by migration and further proliferation in the spleen. To accurately characterize the se-
quence of events involved in the activation and generation of anti-HSV CTLs, we used T cell
receptor (TCR) transgenic mice specific for the immunodominant epitope from HSV glyco-
protein B (gB
 
498–505
 
). We describe the detection of the initiation of antigen presentation in the
draining lymph nodes by 4–6 h after infection with HSV-1. Analysis of CD69 up-regulation
revealed activation of gB-specific CD8
 
 
 
 T cells by 6–8 h after infection. Furthermore, we
show that T cell proliferation begins no sooner than 24 h after activation and is marked by the
concurrent appearance of CTL activity in the PLNs. These events are not dependent on the
presence of virus in the draining lymph nodes, and suggest a requirement for recruitment of
professional antigen-presenting cells to the site of T cell activation. Consequently, we have de-
fined the initiation of the CD8
 
 
 
 T cell–mediated response to cutaneous HSV-1 infection, dem-
onstrating that the immune response to localized viral infection depends only on the appearance
of cells presenting virus-derived antigen and commences with remarkable swiftness.
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Introduction
 
Efficient initiation of the adaptive immune response upon
viral infection is essential to combat a rapidly replicating in-
fectious pathogen. The immune system must be able to re-
spond swiftly while maintaining a high degree of specificity
toward the foreign organism. Two of the most important
factors limiting the rapidity of the immune response soon
after infection are the availability of professional APCs pre-
senting viral antigens and their access to specific T lympho-
cyte precursors in the lymphoid organs draining the site of
infection. During localized infection, APCs are thought to
acquire viral antigens within infected tissues and migrate to
the draining lymphoid tissue where they activate naive T
cells (1). While the migration of professional APCs has
been carefully examined after contact sensitization (2), it
remains unclear how long such migration and antigen
transport takes after immunization with an infectious agent.
The adaptive immune response to cutaneous footpad
HSV-1 infection peaks in the draining popliteal lymph
nodes (PLNs) 5 d after infection (3–5). By this time, there
has been a considerable proliferation of CTLs specific for
the immunodominant epitope from HSV glycoprotein B
(gB
 
498–505
 
) which is followed by migration and further ex-
pansion of this population in the spleen. At the peak of the
response, as many as 5% of the CD8
 
 
 
 T cells in the PLNs
and 10% in the spleen are specific for this determinant (5).
Previous work has estimated the frequency of naive virus-
specific CTL precursors in the mouse to be in the range of
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1 in 10
 
5
 
–10
 
6
 
 (6). Taken together, this suggests that a mas-
sive expansion of the antigen-specific population must oc-
cur relatively soon after infection in order to achieve the
production of such a large CTL population at the height of
the response.
Recently, efforts have been made to quantitate specific
antigen-presenting cells (7), and to follow the development
of effector functions by CD8
 
 
 
 T cells (8) after infection.
Despite this, the kinetics of initial antigen presentation in
combination with the activation and generation of a func-
tional CTL population have not yet been fully elucidated.
To overcome the limitation of low naive CTL precursor
frequencies and effectively analyze the events that occur
immediately after cutaneous infection of C57BL/6 mice
with HSV-1, we have made use of an MHC class I–restricted
TCR transgenic mouse line specific for the gB
 
498–505
 
 deter-
minant (9). Here we describe the rapid activation of the
transgenic CD8
 
 
 
 T cells coinciding with the earliest ap-
pearance of specific APCs in the draining PLNs within
hours of cutaneous infection with HSV-1.
 
Materials and Methods
 
Mice, Viruses, and Peptide.
 
C57BL/6 and the gB-specific, TCR
transgenic MHC class I–restricted (gBT-I.1) mice were obtained
from the Department of Microbiology and Immunology, Uni-
versity of Melbourne, animal house and kept in specific
pathogen-free conditions. The gBT-I.1 transgenic mice express a
TCR from a CTL clone (HSV-2.3) that recognizes the HSV-1
gB
 
498–505
 
 determinant complexed with H-2K
 
b
 
 and is described in
detail elsewhere (9). The KOS strain of HSV-1 was propagated
and titered using VERO cells grown in Minimal Essential Media
plus 10% FCS (MEM-10). The mutant K
 
 
 
318 and K
 
 
 
5C viruses
were propagated and titered on D6•VERO cells grown in MEM-
10 (10). The gB
 
498–505
 
 peptide with the sequence SSIEFARL was
obtained from Auspep.
 
Monoclonal Antibodies and 5-Carboxyfluorescein Diacetate Succini-
midyl Ester Labeling.
 
Cells were labeled with 5-carboxyfluores-
cein diacetate succinimidyl ester (CFSE; Molecular Probes) as
described previously (5). Single cell suspensions prepared from
lymph nodes or spleen were stained with anti-CD8
 
 
 
-allophy-
cocyanin (APC; 53–6.7) and anti-CD69-PE (H1.2F3) ob-
tained from BD PharMingen. 2 
 
 
 
 10
 
6
 
 cells were stained for
20 min on ice and washed with PBS-azide containing 1%
BSA. Dead cells were excluded using propidium iodide and
5–10,000 live CFSE
 
 
 
 events collected on a Becton Dickinson
FACSort™.
 
Adoptive Transfers, Virus Infections, and Peptide Immunizations.
 
Lymph node cells obtained from gBT-I.1 mice containing 
 
 
 
10
 
6
 
CD8
 
 
 
 T cells as determined by flow cytometry were either la-
beled with CFSE or left untreated and transferred into C57BL/6
mice by intravenous injection. 24 h after transfer, mice were in-
jected in each hind footpad with 4 
 
 
 
 10
 
5
 
 PFU HSV-1 KOS,
K
 
 
 
318, or K
 
 
 
5C in PBS, or infected with 10
 
6
 
 pfu HSV-1 by
flank scarification (11). For peptide injection, mice were immu-
nized intravenously with 1 
 
 
 
g of gB
 
498–505
 
 peptide in PBS. The
draining PLN (footpad infection), pooled axillary and inguinal
lymph nodes (flank infection), or spleen (intravenous peptide in-
jection) were removed and single cell suspensions produced and
counted by trypan blue exclusion before antibody staining for
FACS
 
®
 
.
 
In Vivo CTL Assay.
 
Splenocyte target cell suspensions from
C57BL/6 were evenly split into two populations. One was
pulsed with 10
 
 
 
6
 
 M gB
 
498–505
 
 peptide for 45 min at 37
 
 
 
C and
then labeled with a high concentration (2.5 
 
 
 
M) of CFSE (CF-
SE
 
hi
 
 population). The other was incubated for 45 min at 37
 
 
 
C
without peptide and labeled with a low concentration (0.25 
 
 
 
M)
of CFSE (CFSE
 
lo
 
 population). An equal number of cells from
each population (10
 
7
 
) were mixed together and adoptively trans-
ferred into HSV-1–infected mice which were then killed 4 h
later. Cell suspensions were analyzed by FACS
 
®
 
 and each popula-
tion distinguished by their different fluorescent intensities. Per-
cent specific lysis was determined by loss of the peptide-pulsed
CFSE
 
hi
 
 population compared with control CFSE
 
lo
 
 population us-
ing the formula described previously (5).
 
LacZ-inducible Hybridomas, APC Assays, and X-gal Assays.
 
The CTL clone HSV-2.3 was fused with the BWZ.36 cell line
containing the NFAT-lacZ construct (12) to produce the T cell
hybridoma HSV-2.3.2E2. For detection of APCs, PLNs were re-
moved from mice infected with HSV-1 in the footpad at various
times and separately teased into tubes containing 0.5 ml collage-
nase/DNase solution (1 mg/ml collagenase type II [Worthington
Biochemicals] and 0.1% grade II bovine pancreatic DNase I
[Boehringer] in Dulbeccos modified eagles medium plus 10%
FCS). The suspension was then pipetted for 20 min and 50 
 
 
 
l 0.1 M
EDTA added before a further 5 min of pipetting. Twofold serial
dilutions of the cells were made in flat-bottom, 96-well plates
starting at 10
 
6
 
 cells/well. Hybridoma cells (10
 
5
 
) were added to
each well before overnight culture. Background 
 
lacZ
 
 expression
was determined using hybridoma cells alone or with EL4 cells
minus peptide, while positive controls consisted of peptide or
peptide-pulsed EL4 cells. X-Gal assays were performed on the
cultures to identify the responding hybridomas as described pre-
viously (7). Cultures were examined microscopically for the pres-
ence of blue cells after 8–12 h incubation at 37
 
 
 
C.
 
PCR Detection of HSV DNA.
 
The draining PLNs from HSV-1
footpad infected mice were removed at various times after in-
fection and placed into DNAsol™ (Molecular Research Center)
supplemented with proteinase K (50 
 
 
 
g) at room temperature
overnight. A footpad from a mouse primed 24 h earlier was also
removed and digested as above to act as a positive control. Ge-
nomic DNA was isolated as described by the manufacturer’s in-
structions. The HSV-1 DNA was amplified by PCR by using 100
ng of genomic DNA, 50 pmol of primers, 0.2 mM deoxynucleo-
side triphosphate, and 1.5 U of 
 
Taq
 
 polymerase (GIBCO BRL).
The primers used for PCR amplification were HSV-1a (5
 
 
 
-
CCCTGTCTCGCGCGACGGAC-3
 
 
 
) and HSV-1b (5
 
 
 
-
TCACCGACCCATACGCGTAA-3
 
 
 
) (13). Amplification in-
volved 35 cycles of 93
 
 
 
C for 30 s, 55
 
 
 
C for 1 min, and 72
 
 
 
C for 1
min followed by one cycle of 93
 
 
 
C 30 s, 55
 
 
 
C for 1 min, and
72
 
 
 
C for 7 min with a DNA Thermal Cycler (PerkinElmer). For
each specimen, 100 ng of genomic DNA was evaluated for ampli-
fication competence by 25 PCR cycles using insulin primers (5
 
 
 
-
CGAGCTCGAGCCTGCCTATCTTTCAGGTC-3
 
 
 
 and 5
 
 
 
-
CGGGATCCTAGTTGCAGTAGTTCTCCAG-3
 
 
 
). A 20-
 
 
 
l
aliquot of each PCR product was analyzed by electrophoresis on a
2% agarose gel stained with ethidium bromide.
 
Results and Discussion
 
Rapid Recruitment of gB-specific T Cells into the Dividing
Pool and Concurrent Differentiation into Effector Cells.
 
To
examine the early events that give rise to the large CTL 
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pool detectable at the peak of the response to HSV-1 infec-
tion, gBT-I.1 CD8
 
 
 
 T cells were labeled with CFSE (14)
and transferred into normal mice before footpad infection
with HSV-1. The first appearance of a dividing cohort of
CD8
 
 
 
 T cells appeared in the PLNs at 
 
 
 
30 h after infec-
tion (Fig. 1 A). Progressive analysis indicated that these cells
then proceeded to double consistently every 5–6 h thereaf-
ter, having undergone four divisions after 48 h and 
 
 
 
7 di-
visions by 72 h. Initially, very few cells were present in the
dividing pool, as indicated by the relatively small peak of
divided cells at 30 h. However, as the response proceeded
the number of cells that were recruited into the dividing
pool continued to increase, thereby reducing the size of the
undivided population.
The relatively small pool of dividing cells observed early
in the response may reflect either the small number of gB-
specific precursor cells present within the PLNs at the time
of infection, or a limited level of initial antigen presentation
in the PLNs, or both. Due to the limited size of the PLNs,
the number of gB-specific CTL precursors present here in
a naive mouse would be very small, yet these cells would
be stimulated first due to their proximity to the site of in-
fection. A 15–20-fold increase in total cellularity within the
PLNs is observed over the first 24 h after infection (Fig. 1
B), most of which is due to an influx of resting lympho-
cytes (3). The multiple peaks of proliferating cells indicate
that the time for recruitment into the dividing pool varies
as more naive T cells enter the PLNs, yet once activated all
cells divide at a regular rate (15).
While we show that CD8
 
 
 
 T cells first divide at 30 h af-
ter infection, significant CTL activity is not detectable in
the PLNs in normal mice until 2–3 d after infection with
HSV-1 (5), even though CTLs are thought to be armed af-
ter one cell division (16). One possible reason for this delay
is the low precursor frequency in C57BL/6 mice which
prevents detection earlier in the response when cell division
begins. To overcome this limitation we used an in vivo
CTL assay method (17) in combination with the adoptive
transfer of naive gBT-I.1 CD8
 
 
 
 T cells in numbers (10
 
6
 
)
that would greatly exceed the natural precursor frequency
of host gB-specific cells. This enabled the direct detection
of significant CTL activity in the PLNs as early as 30 h after
infection, which continued to increase, more than doubling
over the next 18 h (Fig. 1 C). This data corresponds closely
to the increase in proliferating cells over this same period
(Fig. 1 A), and provides in vivo evidence suggesting that
the first round of division and the development of effector
functions by CD8
 
 
 
 T cells occur simultaneously.
 
De Novo Antigen Synthesis Is Required for Initiation of the
gB-specific Response.
 
Given the very rapid activation of
specific T cells in the PLNs, it was possible that the anti-
gen was derived from the injected virions rather than syn-
thesized de novo upon infection. To exclude this, we
made use of mutant strains of the HSV-1 KOS virus
(K
 
 
 
318 and K
 
 
 
5C) that express defective forms of the gB
protein (10). While both mutants are packaged with a cell
line that supplies the wild-type gB protein, they express
distinct truncated forms of this protein, with only one
Figure 1. Concurrent in vivo proliferation and CTL activity by gB-specific CD8  T cells in the PLNs after cutaneous infection with HSV-1. (A)
CFSE-labeled lymph node cells from gBT-I.1 mice were transferred into C57BL/6 mice before infection with HSV-1. PLN cells were isolated at various
times after infection (24–72 h) and dilution of the CFSE fluorescence analyzed by gating on live CD8  T cells. (B) Cellularity within the draining lymph
nodes over a 48-h period was determined using cell suspensions obtained from the PLNs of mice after foot-pad HSV-1 infection. (C) Mice that had
(black bars) or had not (white bars) received 106 gBT-I.1 cells 24 h earlier were infected with HSV-1 in the footpad and left for various times as shown
before intravenous transfer of CFSE-labeled syngeneic target cells. gB-peptide–pulsed splenocytes were labeled with a high concentration of CFSE (CFSEhi)
while unpulsed control targets were labeled with a low concentration of CFSE (CFSElo). 4 h after target cell transfer, mice were killed and PLN cells an-
alyzed for relative elimination of the CFSEhi versus CFSElo populations. Percent specific lysis was calculated as described in reference 5. Error bars
represent SD. 
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strain (K
 
 
 
318) containing the gB
 
498–505
 
 epitope. Mice
containing CFSE-labeled gBT-I.1 CD8
 
 
 
 T cells were in-
fected cutaneously with the mutant viruses or the wild-
type KOS strain and analyzed for proliferating cells. The
absence of dividing cells after infection with the K
 
 
 
5C
strain, but not the K
 
 
 
318 mutant, indicates that de novo
synthesis of the viral peptides is required in order to stimu-
late a response by CD8
 
 
 
 T cells (Fig. 2). This data rules
out activation of the T cells via antigen obtained from the
injected virions.
 
There Is a 6-h Lag between Infection and T Cell Activation in
the PLNs.
 
It has been shown that CD8
 
 
 
 T cells require a
24-h lag between TCR stimulation and the first division,
possibly to recruit the various cellular machinery required
for division (16). To determine whether this is the case for
gBT-I T cells, mice were immunized intravenously with 1
 
 
 
g gB
 
498–505
 
 peptide after the transfer of CFSE-labeled
transgenic T cells. The use of peptide should provide im-
mediate TCR engagement. As shown in Fig. 3, prolifera-
tion was first observed in the spleen 24 h after immuniza-
tion. This data agrees with the results of Ohen et al. using
LCMV transgenic T cells and peptide stimulation (16).
More importantly, given the observation that cutaneous in-
fection results in appearance of the first cell division within
PLNs at 30 h, we calculate that the HSV-1–specific T cells
are most likely activated 6 h after virus inoculation.
 
In Vivo Antigen Presentation Correlates with CD8
 
 
 
 T Cell
Activation.
 
To directly demonstrate this early activation,
transgenic CD8
 
 
 
 T cells were analyzed for expression of
the early activation marker CD69, which is expressed rap-
idly after TCR engagement (18). Specific up-regulation of
this marker was observed 6 h after infection and further in-
creased after 8 h (Fig. 4 A). This matches the timing of
events predicted from the CFSE proliferation experiments
described above.
The arrival of APCs presenting gB
 
498–505
 
, was deter-
mined using a 
 
lacZ
 
-inducible hybridoma cell line, HSV-
2.3.2E2 expressing the same receptor as the gBT-I.1 trans-
genic mice (9). Suspensions of cells from the PLNs of in-
fected mice were treated with collagenase to isolate DCs
and other APCs, and graded numbers of these cells were
incubated with the LacZ-inducible hybridoma cells. Pre-
sentation of gB
 
498–505
 
 was first detected 4–6 h after cutane-
ous infection (Fig. 4 B) and continued to increase over the
next 48 h.
The combined data shows that synthesis of gB, transport
to the draining lymph nodes, and presentation occurs
within hours of infection. The actual identity of the APCs
involved remains unknown, although recent experiments
using bone marrow chimeric mice has shown that these are
of haemopoietic origin (data not shown). Therefore these
are likely to be professional APCs probably of DC origin
(1). It remains unclear whether presentation involves the
migration of antigen-bearing APCs or the simple transfer of
cell-independent antigen to the draining lymph nodes.
Tracking studies have demonstrated the migration of DCs
from the skin to lymph nodes as early as 30 min after con-
tact sensitization (2). In addition, gB has been shown to be
expressed within 2–3 h of infection (19–21). Taken to-
gether, there is sufficient time for viral infection and pro-
tein synthesis in the epithelium, followed by transport of
antigen via APCs to the PLNs, consistent with the timing
of events described above.
 
Antigen Presentation and T Cell Activation Does Not Require
the Presence of Virus in the Draining Lymph Nodes.
 
Inocula-
tion of mice with HSV-1 via the footpad involves a subcu-
taneous injection that may drain to the PLNs via the lym-
phatics. It was formally possible that direct infection of
APCs in the lymph nodes may have accounted for the
rapid antigen presentation and swift T cell activation after
infection. We attempted to amplify viral DNA from the
PLNs by PCR using HSV-1–specific oligonucleotides
(13). Specific bands were amplified from the PLNs, indi-
cating the presence of significant amounts of viral DNA
Figure 2. De novo synthesis
of viral peptides is required to
elicit a gB-specific T cell re-
sponse. Mice receiving CFSE-
labeled gBT-I.1 CD8  T cells
were infected with wild-type
HSV-1 KOS or the gB mutant
strains K 318 or K 5C. 42 h af-
ter infection, CD8  T cells from
draining PLNs were analyzed for
dilution of the CFSE stain caused
by cell division. Histograms rep-
resent 5–10,000 live events.
Figure 3. Naive T cells require a
minimum 24-h lag between activa-
tion and commencement of prolifer-
ation. Mice receiving CFSE-labeled
gBT-I.1 cells were immunized intra-
venously with gB498–505 peptide and
the transgenic CD8  T cells in the
spleen analyzed 18, 24, and 30 h
later for the presence of dividing
cells. Histograms represent 5–10,000
live events. 
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within 2 h of infection (Fig. 5 A). However, the intensity
of bands amplified 6 and 24 h after infection demonstrate a
rapid decrease in the amount of HSV-1 in the lymph
nodes, and by 48 h we were unable to detect viral DNA
within the PLNs. Moreover, this lack of viral DNA at 48 h
did not correlate with detectable antigen presentation,
which continued to increase over this time period, suggest-
ing that direct APC infection was not necessary for gB-
specific T cell activation.
To verify that the virus did not need to be present in
lymph nodes to initiate a response we infected mice via
scarification of the flank (11). Unlike footpad infection,
scarification removes only the top layer of skin thereby
confining the infection to the upper epithelial layers and
restricting direct viral entry into the dermal lymphatics
(22). Therefore, only antigen transported via APCs should
reach the draining lymph nodes. As predicted, mice in-
fected in the flank displayed no detectable viral DNA in
the draining axillary and inguinal lymph nodes at any time
over the 48 h period after infection (Fig. 5 B). Nonethe-
less, flank inoculation resulted in effective T cell activa-
tion and the same kinetics of proliferation as found using
footpad injection. This was shown by comparing CD8
 
 
 
T cell proliferation 48 h after cutaneous footpad infection
or flank scarification. The number of CFSE
 
 
 
 peaks in the
draining lymph nodes indicated that the gB-specific T
cells were activated at the same time after both routes of
cutaneous infection (Fig. 5 C). Thus, despite the discrep-
ancy in the presence of viral DNA between the two pe-
ripheral infection routes, both showed the same relatively
short lag between infection and activation of the gB-spe-
cific T cells.
Overall, our results suggest that the presence of viral
DNA in the draining PLNs is largely immunologically ir-
relevant, as activation of the gB-specific T cells appears to
occur independent of detectable viral DNA. While HSV-1
can infect DCs, this has been associated with downmodula-
tion of costimulatory molecule expression as well as severe
reduction in the T cell–stimulatory capacity of these cells
(23). Therefore direct DC presentation of HSV-1 antigens
may prove inefficient at T cell priming. Cross-priming,
which involves the transfer of antigen from infected cells to
professional APCs (24), represents an effective means of
Figure 4. Activation of CD8  T cells in the PLNs correlates
with the appearance of specific antigen presentation. (A) Mice
adoptively transferred with CFSE-labeled gBT-I.1 cells were
killed at various times (2–8 h) after footpad infection with HSV-1
and CD8 CFSE  cells analyzed for the expression of CD69. (B)
PLNs from HSV-1–infected C57BL/6 mice were treated with
collagenase to form a cell suspension. Graded amounts of these
cells were placed into culture with HSV-2.3.2E2 lacZ-inducible
hybridoma cells overnight. An X-Gal assay was then performed
to stain responding hybridoma cells which were counted mi-
croscopically. Numbers presented represent the total number
of lacZ  cells per separate PLN at various times (2–48 h) after
infection, and error bars represent SD (n   8–12).
Figure 5. Activation of the gB-specific T cells does not require the
presence of viral DNA in the draining lymph nodes. Mice were killed at
various times (2–48 h; N, naive) after footpad infection (A), or after flank
scarification (B) and DNA isolated from the draining PLNs or pooled ax-
illary and inguinal lymph nodes, respectively. 100 ng of DNA was ampli-
fied by PCR using HSV-1 or insulin-specific primers. DNA from the
footpad of a mouse infected 24 h earlier was used as a positive control
( ). A no DNA control was included to rule out contamination ( ). (C)
Mice receiving CFSE-labeled gBT-I.1 cells were infected with HSV-1 by
footpad injection or flank scarification, and CD8  T cells from the PLNs
or pooled axillary and inguinal lymph nodes, respectively, were analyzed
for the presence of proliferating cells via CFSE intensity at 48 h after in-
fection. Histograms represent 5–10,000 live events. 
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achieving T cell activation circumventing HSV-mediated
immune evasion (25). In addition, cross-presentation of an-
tigen at a site remote from the actual infection would ex-
plain the absence of HSV-1 DNA within the draining axil-
lary and inguinal lymph nodes. The rapidity with which
antigen transfer occurs so soon after cutaneous infection
suggests that this is a very efficient event. As shown here,
antigen presentation appears in draining lymph nodes
within 6 h of infection. Most importantly, even at this
time, presentation is at levels clearly capable of initiating an
effective CTL response.
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